| Thymus Neoplasm studied in …STUDIED_INderived200 of 283show all (up to 200) |
|---|
| → studied in | NCT01242072Phase 1 · completed Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04231877Phase 1 · active not recruiting Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02146170recruiting Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03076554Phase 2 · active not recruiting A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06784167recruiting Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03375320Phase 3 · active not recruiting Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07006727Phase 1 · recruiting Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Thymus Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05359211Phase 1 · completed NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06980077Phase 2 · recruiting Ivonescimab for the Treatment of Thymic Cancer · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03968315NA · active not recruiting An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Malignant Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05025800Phase 1/Phase 2 · active not recruiting ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07824505Phase 2 · completed Lucitanib (AL3810) in Patients With Advanced Thymic Carcinoma After Chemotherapy · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05150210NA · active not recruiting SP Thoracic IDE Study · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07168486Phase 1 · enrolling by invitation CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05934084NA · recruiting Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06248515Phase 2 · recruiting A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06830031Phase 1 · recruiting Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07098364Phase 1/Phase 2 · suspended ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07181720Phase 1 · suspended CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04759586Phase 3 · active not recruiting Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03625037Phase 1/Phase 2 · active not recruiting First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04542824Phase 1/Phase 2 · active not recruiting Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL) · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07225439Phase 1 · recruiting Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL) · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01950572recruiting Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04417660Phase 2 · active not recruiting Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma · condition mapped PROBABILISTIC · 283 trials mapped (130 active) | — | — | Thymus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05104736Phase 2 · recruiting PT-112 in Subjects With Thymoma and Thymic Carcinoma · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06784726Phase 2 · recruiting Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07365306Phase 2 · recruiting Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04464200Phase 1 · active not recruiting 19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06885697Phase 1 · recruiting Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07788118Phase 1/Phase 2 · recruiting A Phase Ib/II Exploratory Clinical Trial of Memory-Enhanced 7×19-THEMIS CAR-T Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06536049Phase 1/Phase 2 · recruiting Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07735533Phase 1/Phase 2 · not yet recruiting A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07324629Phase 2 · recruiting Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic Carcinoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05075603Phase 1 · completed Relapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell Therapy · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06486051Phase 2 · recruiting A Study of Atlacabtagene Autoleucel CAR T-cells for Adults With Relapsed Large B-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03463460Phase 2 · active not recruiting Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06533579Phase 1/Phase 2 · recruiting Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19) · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07750353Phase 2 · not yet recruiting A Phase II, Investigator-Initiated Exploratory Study of Sacituzumab Tirumotecan for Previously Treated Unresectable Thymic Carcinomas · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07750886recruiting Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL) · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06116110recruiting Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01025089Phase 2 · active not recruiting Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05821088Phase 2 · active not recruiting Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07714421Phase 1 · not yet recruiting Epcoritamab and Pola-R-mini-CHP for the Treatment of Diffuse Large B Cell Lymphoma in Elderly or Unfit Patients · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03295227Phase 1 · recruiting Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07693855NA · not yet recruiting Hypofractionated Adjuvant Radiotherapy for Thymic Epithelial Tumors · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04792489Phase 2 · recruiting DALY II USA/ MB-CART2019.1 for DLBCL · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05077527Phase 1 · recruiting Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05672251Phase 2 · recruiting Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07691619Phase 2 · recruiting Hypofractionated Radiotherapy After Complete Resection for Stage II/III Thymic Epithelial Tumors · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06996249recruiting Prospective Data Collection Initiative on Thoracic Malignancies · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Malignant Thymus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07118176Phase 1 · active not recruiting Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04836507Phase 1/Phase 2 · recruiting Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05653271Phase 1 · completed ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02012699recruiting Integrated Cancer Repository for Cancer Research · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Malignant Thymus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04257578Phase 1/Phase 2 · active not recruiting Acalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell Lymphoma · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06790706Phase 2 · active not recruiting IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04545762Phase 1 · recruiting Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07652476not yet recruiting Neurocognitive Assessment in Long-Term Survivors of Lymphoma · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07649187NA · completed Depressive Tendency and Counseling Outcomes in Thymoma-Associated MG · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01787409NA · active not recruiting Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06189183NA · active not recruiting Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06985576enrolling by invitation Long-term Study to Evaluate Safety and Persistence of GF-CART01 · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06271057Phase 2 · recruiting Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05162170completed Primary Mediastinal Large B-cell Lymphoma (PMBCL): Multicenter Retrospective Study · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07598955Phase 1/Phase 2 · recruiting Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2 Thymoma or Thymic Carcinoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03134118Phase 2 · active not recruiting Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM) · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma Type B3 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02362035Phase 1/Phase 2 · completed ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03038672Phase 2 · active not recruiting Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05918302Phase 3 · recruiting Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus. · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06019468Phase 2 · recruiting Neoadjuvant Treatment For Locally Advanced Thymic Cancer · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06014762Phase 1 · active not recruiting P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07571525not yet recruiting Thymic Disease, Autoimmunity, and Neuromuscular Junction Integrity in Myasthenia Gravis · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01851395terminated Rapid Autopsy and Procurement of Cancer Tissue · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Thymus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03035331Phase 1/Phase 2 · completed Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05366569recruiting Bio-CAR-T BS Study · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02633514Phase 3 · withdrawn Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06402708Phase 3 · recruiting Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3) · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02633553NA · recruiting Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07097363Phase 2 · recruiting Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05507541Phase 2 · active not recruiting TTI-622 in Combination With Pembrolizumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05757700Phase 1 · active not recruiting Study of 19(T2)28z1xx TRAC-Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Lymphoma · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04375267Phase 1 · completed 177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06544265Phase 1 · recruiting SynKIR-310 for Relapsed/Refractory B-NHL · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05461430completed Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04911478active not recruiting Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06141369NA · recruiting Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Thymus Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04488354Phase 1 · completed Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06208735Phase 1 · recruiting CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07479628Phase 2 · not yet recruiting Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06026319Phase 1 · recruiting CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07473167Phase 1/Phase 2 · recruiting Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07463781not yet recruiting Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05934448Phase 2 · recruiting Pembro Plus CAR T-cell Therapy in R/R in PMBCL · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04186520Phase 1/Phase 2 · recruiting CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04710628Phase 2 · completed Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05544019Phase 1 · recruiting Study of SGR-1505 in Mature B-Cell Neoplasms · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04067414Phase 1 · completed Exploratory Study of CD19-targeted Chimeric Antigen Receptor T Cells(BZ019) for Relapsed and Refractory B-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01516567Phase 2 · completed Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07383142NA · not yet recruiting Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence (CHOICE-2) · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04459273Phase 1 · active not recruiting Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Malignant Thymus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07328074not yet recruiting Electrocautery Resection Combined With HITHOC for Thymic Epithelial Tumors With Pleural Metastasis · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05633615Phase 2 · recruiting Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04745559Phase 2 · active not recruiting Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05583149Phase 2 · active not recruiting Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06834373Phase 2 · recruiting Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01599559NA · active not recruiting Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07343453Phase 2 · not yet recruiting A Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan in Second-Line and Subsequent Treatments for Advanced Thymic Epithelial Tumors · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03210662Phase 2 · completed Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05544929Phase 1 · active not recruiting A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01385722enrolling by invitation Molecular Analysis of Thoracic Malignancies · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Malignant Thymus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07283822Phase 2 · recruiting Amping up With PemJAK · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06004167NA · completed Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T) · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06838910Phase 2 · recruiting Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06550141Phase 2 · recruiting Emapalumab Prevention of CAR-T Cell Associated Toxicities · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03694002Phase 2 · completed Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04875195Phase 2 · completed A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68) · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01760226early Phase 1 · completed Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05940272NA · recruiting Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05621096Phase 1 · active not recruiting Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07179341NA · completed Survival Nomogram for Patients With Thymic Carcinoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02393157Phase 2 · recruiting Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07072143recruiting An International Study on Pediatric Patients With Rare Tumors. · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Thymus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04833504completed Clinical Follow-up Study of CD19 CAR-T Expressing IL7 and CCL19 for Relapsed or Refractory B Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06024694active not recruiting Primary Mediastinal Large B-cell Lymphoma With CNS Involvement · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001337Phase 2 · completed Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04735471Phase 1 · terminated A Phase 1 Study of ADI-001 in B Cell Malignancies · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06186726Phase 2 · recruiting Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06311955Phase 2 · recruiting Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06311968Phase 2 · recruiting The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05667948recruiting Molecular Analysis and Treatment Options of Thymic Malignancies · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05326243Phase 1/Phase 2 · recruiting Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05377307recruiting Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06871007Phase 1/Phase 2 · enrolling by invitation Nivolumab and DA-EPOCH-R in Pediatric Primary Mediastinal (Thymic) Large B-cell Lymphoma · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03484819Phase 2 · completed Copanlisib Hydrochloride and Nivolumab in Treating Patients With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell Lymphoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06093841Phase 2 · active not recruiting Relmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHL · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06464861Phase 1 · recruiting Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06781450recruiting Study in Patients With Relapsed/Refractory Primary Mediastinal Lymphoma Treated With Pembrolizumab or Nivolumab in Combination With Brentuximab Vedotin in a Real-life Context · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04432506Phase 2 · completed Anakinra for the Reduction of CAR-T Toxicity in Patients With Relapsed or Refractory Large B-cell Lymphoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06796517recruiting Immunotherapy in Lymphoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05255965completed IL-8+ naïve T Cells as a Biomarker for Thymoma Identification · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06750952Phase 2 · not yet recruiting Ivonescimab Combined with Chemotherapy As First-line Treatment of Relapsed or Metastatic Thymic Cancer: a Prospective, Single Arm, Phase II Trial · condition mapped PROBABILISTIC · 283 trials mapped (130 active) | — | — | Thymus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04028479completed The Registry of Oncology Outcomes Associated With Testing and Treatment · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Malignant Thymus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06730308Phase 2 · recruiting Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04985357withdrawn Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06692062NA · recruiting Hypofractionated Radiotherapy for Thymic Epithelial Tumors · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06654830Phase 2 · not yet recruiting RATT Vs. VATT for Early-stage TETs · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04358458Phase 1/Phase 2 · terminated First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05683886Phase 2 · recruiting A Study of KC1036 in Patients with Advanced Thymic Tumors · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Thymus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05202782Phase 2 · active not recruiting Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03583086Phase 1/Phase 2 · completed Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01306045Phase 2 · completed Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06238648Phase 2 · recruiting Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01621568Phase 2 · completed Sunitinib for Advanced Thymus Cancer Following Earlier Treatment · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04049513Phase 1 · active not recruiting ENABLE-1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy) · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04450069Phase 1 · completed CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04806035Phase 1 · terminated Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05214612unknown Predictors and Prognostic Factors of Myasthenia Gravis Outcome · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06523582recruiting Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Thymus Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04072393NA · terminated Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02628405Phase 1/Phase 2 · unknown R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02631044Phase 1 · completed Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001) · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04321330Phase 2 · completed A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02348216Phase 1/Phase 2 · completed Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05682742NA · active not recruiting Clinical Investigation of the da Vinci Surgical System · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03921671Phase 2 · unknown Ramucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma / B3 Thymoma With Carcinoma (RELEVENT) · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06421805recruiting Establishing Prospective Mediastinal Tumor Database of PUMCH · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06412068Phase 2 · unknown A Prospective Study: Sintilimab and R-CHOP in PMBCL Treatment · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04925947Phase 2 · terminated A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03103971Phase 1 · terminated huJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06200233Phase 2 · not yet recruiting Rivoceranib in Patients With Metastatic Thymic Epithelial Tumor · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06339255recruiting Italian Observational Study on CAR-T Therapy for Lymphoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06301945recruiting Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01897571Phase 1/Phase 2 · completed Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04469725Phase 2 · terminated KN046 (a Humanized PD-L1/CTLA4 Bispecific Single Domain Fc Fusion Protein Antibody) in Subjects With Thymic Carcinoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06029621NA · recruiting Robot-assisted vs VATS for Thymoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04858568completed Immune Responses to COVID-19 Vaccination in Lymphoma Patients · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04187872Phase 1 · terminated LITT and Pembrolizumab in Recurrent Brain Metastasis · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04870853unknown Cardiovascular Events Among Adults Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Standard of Care Chimeric Antigen Receptor T Cell Therapy · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05455840NA · unknown A Prospective, Single-Center Investigation of the da Vinci SP® Surgical System in Anterior Mediastinal Disease · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04662645NA · completed Embedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancies and Their Caregivers · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05832827Phase 2 · recruiting First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis) · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06086327early Phase 1 · unknown Application of 68Ga-Pentixafor PET/CT for Thymoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06010277Phase 4 · unknown Folinic Acid for Prevention of Pemetrexed-induced Toxicity · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02576990Phase 2 · completed Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170) · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00010257Phase 2 · completed Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003283Phase 2 · completed Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00591981completed Thoracic OncoGeriatric Assessment (TOGA) Trials · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05733650approved for marketing Expanded Access Program for Epcoritamab · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02724696unknown French National Observatory of Patients With Thymic Epithelial Tumor · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05130489completed CAR T Cell Therapy Related Cardiovascular Outcomes · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04526834Phase 1 · active not recruiting Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05816694Phase 2 · unknown The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train. · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04667793Phase 2 · unknown Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04323657Phase 1/Phase 2 · completed TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04276597Phase 2 · withdrawn Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET. · condition mapped ALIAS · 283 trials mapped (130 active) | — | — | Thymus Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03193437Phase 2 · terminated Selinexor in Patients With Advanced Thymic Epithelial Tumor Progressing After Primary Chemotherapy · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04430842Phase 1 · completed Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04162691unknown Single Cell Sequencing Analysis of Thymoma · condition mapped ONTOLOGY_EXACT · 283 trials mapped (130 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05228249Phase 1 · withdrawn Loncastuximab Tesirine in Combination With Chemotherapy Prior to Stem Cell Transplant for the Treatment of Recurrent or Refractory Diffuse Large B-Cell Lymphoma · condition mapped CURATED_BROADER · 283 trials mapped (130 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |